IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vanda Pharmaceuticals Inc

CUSIP: 92165910 | 3 institutional holders

Quarters

Q3 2013Q2 2013
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2013

Arrowstreet Capital, Limited Partnership13,044
0.0% of portfolio›$143
StyleTurnoverLocationFiled
Arrowstreet Capital, Limited Partnership
13,044$1430.0%GARPHighBoston, MA2013-11-14